Submitter Withdrawn 21st Lancefield International Symposium for Streptococci and Streptococcal Diseases 2022

Group B streptococcal bacteraemia: changing trends in a tropical region of Australia (#331)

Mohammed . Alizzi 1 2 , Romesh . Rathnayake 1 , Pirathaban . Sivabalan 1 2 , Theophilus I. Emeto 3 4 , Robert . Norton 1 2
  1. Townsville University Hospital, Douglas, QLD, Australia
  2. School of Medicine, James Cook University, Townsville, QLD, Australia
  3. College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD, Australia
  4. Australian Insititute of Tropical Health and Medicine, James Cook University, Townsville, QLD, Australia

Background

Group B streptococcus (GBS) is a recognised perinatal and neonatal pathogen. There are reports of increasing GBS sepsis globally outside this demographic. North Queensland is part of tropical Australia, with a relatively high proportion of Indigenous Australians. This study aims to analyse the epidemiology of GBS bacteraemia and explore associated risk factors.

 

Methods

This was a 10-year retrospective review of GBS bacteraemia in a tertiary facility in North Queensland, between 2010 and February 2020. Data variables collected included; demographics, risk factors, clinical source and outcomes. Multivariable logistic regression was performed to examine the association of Indigenous status and other relevant clinical factors with mortality from GBS bacteraemia at three months.

 

Results

Of the 164 total cases, 123 were not pregnancy related. The annual rate of GBS bacteraemia for the Indigenous population was 12.48 per 100, 000 and 4.84 per 100, 000 for the non-Indigenous population. Indigenous patients were more likely to be diabetic and have chronic kidney disease compared to the non-Indigenous patients. Males [AOR = 4.34, 95% CI (1.14, 16.56), P=0.031] and immunosuppressed patients, [AOR = 11.49, 95% CI (2.73, 48.42), P<0.001] were more likely to experience mortality at three months from GBS bacteraemia even after adjusting for other risk factors respectively.

 

Conclusion

GBS bacteraemia is deviating from being primarily a neonatal disease. While the Indigenous population of North Queensland have a disproportionate burden of GBS disease, the demographics affected differ. GBS appears to target the older non-Indigenous patients with greater comorbidities. 3-month mortality appears to be increased in males and the immunosuppressed.